Osteopontin in patients with chronic obstructive pulmonary disease and coronary heart disease

Background: Osteopontin is a protein expressed by various cell types, such as endothelial and epithelial cells, osteoclasts, hepatocytes, smooth muscle cells, activated macrophages, and T-cells. Cardiomyocytes, heart fibroblasts, endothelial cells of coronary arteries express osteopontin in response...

Full description

Bibliographic Details
Published in:	Alʹmanah Kliničeskoj Mediciny
Main Authors:	Natalia A. Suvorova, Ivan G. Gordeev, Elena E. Luchinkina
Format:	Article
Language:	Russian
Published:	MONIKI 2023-05-01
Subjects:	chronic obstructive pulmonary disease osteopontin systemic inflammation predictor coronary heart disease
Online Access:	https://almclinmed.ru/jour/article/viewFile/1759/1547

Similar Items

Osteopontin in Cardiovascular Diseases
by: Kohsuke Shirakawa, et al.
Published: (2021-07-01)

Coronary artery status in patients with coronary heart disease and chronic obstructive pulmonary disease: results of selective coronary angiography
by: N. Yu. Grigorieva, et al.
Published: (2012-10-01)

Osteopontin as Candidate Biomarker of Coronary Disease despite Low Cardiovascular Risk: Insights from CAPIRE Study
by: Federico Carbone, et al.
Published: (2022-02-01)

Predictive value of neutrophil to lymphocyte ratio for the complication of coronary heart disease in patients with chronic obstructive pulmonary disease
by: HUANG Minjie*，TAO Jun，LI Jie，WANG Zhi，LU Zhiping，XU Junwei
Published: (2025-06-01)

Importance of early diagnostics of chronic obstructive pulmonary disease in patients with coronary heart disease
by: A. N. Kuznetsov, et al.
Published: (2011-06-01)

Osteopontin in Pulmonary Hypertension
by: Argen Mamazhakypov, et al.
Published: (2023-05-01)

The combined drug ascoril in the treatment of patients with chronic obstructive pulmonary disease concurrent with coronary heart disease
by: N Iu Grigor'eva, et al.
Published: (2013-08-01)

Osteopontin as a Biomarker for Coronary Artery Disease
by: Georgia R. Layton, et al.
Published: (2025-01-01)

INFLUENCE OF THE CHRONIC OBSTRUCTIVE PULMONARY DISEASE ON POST-OPERATION COURSE IN CORONARY HEART DISEASE
by: A. S. Klinkova, et al.
Published: (2016-04-01)

Research Status and Direction of Chronic Obstructive Pulmonary Disease Complicated with Coronary Heart Disease: A Bibliometric Analysis from 2005 to 2024
by: Bian H, et al.
Published: (2025-01-01)

ANTIISCHEMIC EFFECTIVENESS OF IVABRADINE AND ITS IMPACT ON MICROCIRCULATION IN PATIENTS WITH CORONARY HEART DISEASE ASSOCIATED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: A. A. Garganeeva, et al.
Published: (2012-08-01)

Manifestations of Cellular Anomalies of Gingival Epithelium in Patients with Chronic Obstructive Pulmonary Diseases Combined with Coronary Heart Disease
by: Emelyanova N.
Published: (2017-09-01)

Angiogenin and osteopontin and coronary collateral circulation
by: Joob Beuy, et al.
Published: (2019-09-01)

Osteopontin as a Biomarker in Interstitial Lung Diseases
by: David Iturbe-Fernández, et al.
Published: (2024-05-01)

Dynamics of characteristics of respiratory function for the development of coronary heart disease in patients with chronic obstructive lung disease
by: D. A. Vishnyak, et al.
Published: (2019-03-01)

Osteopontin Gene Polymorphisms Are Associated with Cardiovascular Risk Factors in Patients with Premature Coronary Artery Disease
by: Nonanzit Pérez-Hernández, et al.
Published: (2021-11-01)

Osteopontin as a Biomarker in Chronic Kidney Disease
by: Satyesh K. Sinha, et al.
Published: (2023-05-01)

Comparative effectiveness of ACE inhibitors spirapril, fosinopril, and enalapril in complex therapy of patients with coronary heart disease, chronic obstructive pulmonary disease, and arterial hypertension
by: M. A. Popova, et al.
Published: (2006-06-01)

Predictors and Prevalence of Obstructive Coronary Artery Disease in Patients Who Underwent Elective Invasive Coronary Angiography for Chronic Coronary Syndrome [Letter]
by: Nugroho HSW
Published: (2024-05-01)

Osteopontin in chronic obstructive pulmonary disease: Smokers and ex-smokers
by: Ahmed A Ali, et al.
Published: (2015-01-01)

Nomogram Model for Identifying the Risk of Coronary Heart Disease in Patients with Chronic Obstructive Pulmonary Disease Based on Deep Learning Radiomics and Clinical Data: A Multicenter Study
by: Bian H, et al.
Published: (2025-09-01)

Endothelial dysfunction in patients with chronic obstructive pulmonary disease in combination with coronary heart disease
by: N A Karoli, et al.
Published: (2019-03-01)

INFLUENCE OF SOMATIC COMORBIDITY ON THE COURSE OF CORONARY HEART DISEASE
by: E. B. Akhmedova, et al.
Published: (2017-10-01)

FORECASTING CORONARY EVENTS BASED ON THE ANALYSIS OF THE DYNAMICS OF MORPHOFUNCTIONAL PARAMETERS OF THE CARDIOVASCULAR SYSTEM IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THE NORTH
by: D. A. Dolgopolova, et al.
Published: (2018-02-01)

Predictors of Readmission, for Patients with Chronic Obstructive Pulmonary Disease (COPD) – A Systematic Review
by: Chow R, et al.
Published: (2023-11-01)

Role of Osteopontin as a Potential Biomarker of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis and Other Connective Tissue Diseases (CTDs)
by: Mattia Bellan, et al.
Published: (2021-04-01)

Association of serum levels of osteopontin and osteoprotegerin with adverse outcomes after endovascular revascularisation in peripheral artery disease
by: Nikolaos P. E. Kadoglou, et al.
Published: (2022-09-01)

The Role of Osteopontin in Atherosclerosis and Its Clinical Manifestations (Atherosclerotic Cardiovascular Diseases)—A Narrative Review
by: Nikolaos P. E. Kadoglou, et al.
Published: (2023-11-01)

Predictors of mortality in patients of acute exacerbation of chronic obstructive pulmonary disease: A prospective observational study
by: Hemant Kumar, et al.
Published: (2018-01-01)

Diagnostic Role of Osteopontin in Interstitial Lung Disease
by: Meena Goyal, et al.
Published: (2021-03-01)

IVABRADINE EFFECTIVENESS IN PATIENTS WITH CORONARY HEART DISEASE AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE AFTER CORONARY ARTERY BYPASS GRAFT SURGERY
by: I. V. Kochetkova, et al.
Published: (2014-04-01)

Clinical characteristics and predictors of pulmonary hypertension in chronic obstructive pulmonary disease at different altitudes
by: Lixia Wang, et al.
Published: (2023-04-01)

Prognostic significance of pulmonary ventilation disorders in the development of arrhythmia recurrence in patients with chronic obstructive pulmonary disease and paroxysmal atrial fibrillation
by: Valery I. Podzolkov, et al.
Published: (2025-01-01)

Pericardial effusion predicts mortality in patients with chronic obstructive pulmonary disease
by: Can Yücel Karabay, et al.
Published: (2015-01-01)

The association between serum angiogenin and osteopontin levels and coronary collateral circulation in patients with chronic total occlusion
by: Kadri Murat Gürses, et al.
Published: (2019-08-01)

Changes and significance of high-density lipoprotein A-I, A-II, and serum amyloid levels in patients with chronic obstructive pulmonary disease complicated by coronary heart disease
by: Yao Tian, et al.
Published: (2025-12-01)

Contextualizing the Role of Osteopontin in the Inflammatory Responses of Alzheimer’s Disease
by: Roshni C. Lalwani, et al.
Published: (2023-12-01)

Influence of chronic obstructive pulmonary disease on hospital outcomes of percutaneous coronary interventions in patients with acute coronary syndrome
by: Alexey A. Frolov, et al.
Published: (2024-04-01)

The relationship of chronic obstructive pulmonary disease and coronary heart disease: problems of pathogenesis and treatment strategy
by: O. V. Yatsenko
Published: (2014-06-01)

METHOD FOR THE PREDICTION OF THE DEVELOPMENT OF CHRONIC PULMONARY HEART IN COAL WORKERS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: O. Yu. Korotenko, et al.
Published: (2013-05-01)